ETFChannel.com
WisdomTree BioRevolution Fund

Fund Name:
WisdomTree BioRevolution Fund
Issuer:
WisdomTree
Total Net Assets:
$2,688,014
Inception:
06/03/2021
Related Index:
ETF Category: 
Energy
Expense Ratio: 
0.45% 
Net Asset Value: 
$16.80  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
WDNA.NV  
Number of Holdings: 
99  
Annualized Yield: 
1.25%  
Annualized Distribution: 
0.210  
WDNA Dividend History » 
Stock Weight Amount
Astrazeneca Plc-spons Adr 3.05% $82,403.94
Vertex Pharmaceuticals 2.50% $67,306
Sarepta Therapeutics 2.26% $60,790
Merck & Co INC/NJ 2.18% $58,502
Thermo Fisher Scientific 2.17% $58,450
List of all 99 stocks held by WDNA »
Quotes delayed 20 minutes

Email EnvelopeFree WDNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.19 out of 4)
46th percentile
(ranked lower than approx. 54% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
USFR   $14,640,865,375
DGRW   $7,625,291,377
DLN   $3,412,907,080
DON   $3,185,804,363
DGS   $2,616,296,563
List of all 79 others »

WDNA | WisdomTree BioRevolution Fund | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.